Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).

Hernández Cruz B, Alonso F, Calvo Alén J, Pego-Reigosa JM, López-Longo FJ, Galindo-Izquierdo M, Olivé A, Tomero E, Horcada L, Uriarte E, Erausquin C, Sánchez-Atrio A, Montilla C, Santos Soler G, Fernández-Nebro A, Blanco R, Rodríguez-Gómez M, Vela P, Freire M, Díez-Álvarez E, Boteanu AL, Narváez J, Martínez Taboada V, Ruiz-Lucea E, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Pérez-Venegas JJ, Ibáñez-Barceló M, Pecondón-Español Á, Marras C, Bonilla G, Castellví I, Moreno M, Raya E, Quevedo Vila VE, Vázquez T, Ruán JI, Muñoz S, Rúa-Figueroa Í; RELESSER (Spanish Society of Rheumatology Systemic Lupus Erythematosus register) group.

Lupus. 2019 Dec 4:961203319889667. doi: 10.1177/0961203319889667. [Epub ahead of print]

PMID:
31801040
2.

Hormonal dependence and cancer in Systemic Lupus Erythematosus.

Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM.

Arthritis Care Res (Hoboken). 2019 Sep 17. doi: 10.1002/acr.24068. [Epub ahead of print]

PMID:
31529686
3.

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.

Rúa-Figueroa I, López-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narváez J, Olivé A, Freire M, Salgado E, Andreu JL, Martínez-Taboada V, Calvo-Alén J, Hernández-Cruz B, Raya E, Quevedo V, Expósito Pérez L, Fernández-Nebro A, Ibañez M, Pascual-Valls È, Rúa-Figueroa D, Naranjo A, Pego-Reigosa JM.

J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882. [Epub ahead of print]

PMID:
30988123
4.

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.

Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD, Raya E, Magro-Checa C, Vasilopoulos Y, Caliz R, Ferrer MA, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco FJ, Moreno-Ramos MJ, Manrique-Arija S, Ordoñez MDC, Alegre-Sancho JJ, Narvaez J, Navarro-Sarabia F, Moreira V, Valor L, Garcia-Portales R, Marquez A, Gomez-Reino JJ, Martin J, Gonzalez A.

PLoS One. 2019 Feb 28;14(2):e0213073. doi: 10.1371/journal.pone.0213073. eCollection 2019.

5.

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.

Calderón-Goercke M, Loricera J, Aldasoro V, Castañeda S, Villa I, Humbría A, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, Olivé-Marqués A, Álvarez Del Buergo M, Marena-Rojas L, Fernández-López C, Navarro F, Raya E, Galindez-Agirregoikoa E, Arca B, Solans-Laqué R, Conesa A, Hidalgo C, Vázquez C, Román-Ivorra JA, Lluch P, Manrique-Arija S, Vela P, De Miguel E, Torres-Martín C, Nieto JC, Ordas-Calvo C, Salgado-Pérez E, Luna-Gomez C, Toyos-Sáenz de Miera FJ, Fernández-Llanio N, García A, Larena C, Palmou-Fontana N, Calvo-Río V, Prieto-Peña D, González-Vela C, Corrales A, Varela-García M, Aurrecoechea E, Dos Santos R, García-Manzanares Á, Ortego N, Fernández S, Ortiz-Sanjuán F, Corteguera M, Hernández JL, González-Gay MÁ, Blanco R.

Semin Arthritis Rheum. 2019 Aug;49(1):126-135. doi: 10.1016/j.semarthrit.2019.01.003. Epub 2019 Jan 5.

PMID:
30655091
6.

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA.

Arthritis Rheumatol. 2019 Mar;71(3):351-360. doi: 10.1002/art.40734. Epub 2019 Jan 18.

7.

Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

Cea-Calvo L, Raya E, Marras C, Salman-Monte TC, Ortiz A, Salvador G, Monteagudo I, Carmona L, Fernandez S, Arteaga MJ, Calvo-Alén J.

Rheumatol Int. 2018 Sep;38(9):1741. doi: 10.1007/s00296-018-4113-2.

PMID:
30046842
8.

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

Cea-Calvo L, Raya E, Marras C, Salman-Monte TC, Ortiz A, Salvador G, Monteagudo I, Carmona L, Fernandez S, Arteaga MJ, Calvo-Allén J.

Rheumatol Int. 2018 Sep;38(9):1735-1740. doi: 10.1007/s00296-018-4097-y. Epub 2018 Jun 29. Erratum in: Rheumatol Int. 2018 Jul 25;:.

PMID:
29959469
9.

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.

González-Serna D, Ortiz-Fernández L, Vargas S, García A, Raya E, Fernández-Gutierrez B, López-Longo FJ, Balsa A, González-Álvaro I, Narvaez J, Gómez-Vaquero C, Sabio JM, García-Portales R, González-Escribano MF, Tolosa C, Carreira P, Kiemeney L, Coenen MJH, Witte T, Schneider M, González-Gay MÁ, Martín J.

Sci Rep. 2018 May 29;8(1):8195. doi: 10.1038/s41598-018-26573-4.

10.

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.

Lopez-Rodriguez R, Perez-Pampin E, Marquez A, Blanco FJ, Joven B, Carreira P, Ferrer MA, Caliz R, Valor L, Narvaez J, Cañete JD, Ordoñez MDC, Manrique-Arija S, Vasilopoulos Y, Balsa A, Pascual-Salcedo D, Moreno-Ramos MJ, Alegre-Sancho JJ, Navarro-Sarabia F, Moreira V, Garcia-Portales R, Raya E, Magro-Checa C, Martin J, Gomez-Reino JJ, Gonzalez A.

PLoS One. 2018 May 7;13(5):e0196793. doi: 10.1371/journal.pone.0196793. eCollection 2018.

11.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

Silva-Fernández L, Otón T, Askanase A, Carreira P, López-Longo FJ, Olivé A, Rúa-Figueroa Í, Narváez J, Ruiz-Lucea E, Andrés M, Calvo E, Toyos F, Alegre-Sancho JJ, Tomero E, Montilla C, Zea A, Uriarte E, Calvo-Alén J, Marras C, Martínez-Taboada VM, Belmonte-López MÁ, Rosas J, Raya E, Bonilla G, Freire M, Pego-Reigosa JM, Millán I, Hughes-Morley A, Andreu JL; from the Spanish Society for Rheumatology Systemic Autoimmune Diseases Study Group (EAS-SER).

Reumatol Clin. 2019 Jan - Feb;15(1):34-42. doi: 10.1016/j.reuma.2017.04.005. Epub 2017 May 18. English, Spanish.

12.

Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.

Marras C, Monteagudo I, Salvador G, de Toro FJ, Escudero A, Alegre-Sancho JJ, Raya E, Ortiz A, Carmona L, Mestre Y, Cea-Calvo L, Calvo-Alén J.

Rheumatol Int. 2017 Jul;37(7):1195-1202. doi: 10.1007/s00296-017-3737-y. Epub 2017 May 17.

PMID:
28516236
13.

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM.

Semin Arthritis Rheum. 2017 Aug;47(1):38-45. doi: 10.1016/j.semarthrit.2017.01.010. Epub 2017 Jan 27.

PMID:
28259425
14.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

15.

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán JV, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C.

Clin Exp Rheumatol. 2017 May-Jun;35(3):423-430. Epub 2016 Dec 28.

PMID:
28032846
16.

Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity.

García-Rodríguez S, Arias-Santiago S, Blasco-Morente G, Orgaz-Molina J, Rosal-Vela A, Navarro P, Magro-Checa C, Martínez-López A, Ruiz JC, Raya E, Naranjo-Sintes R, Sancho J, Zubiaur M.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):312-322. doi: 10.1111/jdv.13861. Epub 2016 Aug 17.

PMID:
27535005
17.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

18.

Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain.

Nolla JM, Rodríguez M, Martin-Mola E, Raya E, Ibero I, Nocea G, Aragon B, Lizán L, Prades M.

Patient Prefer Adherence. 2016 Jun 20;10:1101-13. doi: 10.2147/PPA.S106311. eCollection 2016.

19.

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.

Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ.

Rheumatology (Oxford). 2016 Jul;55(7):1243-50. doi: 10.1093/rheumatology/kew049. Epub 2016 Mar 27.

PMID:
27018057
20.

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I; RELESSER Group, from Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).

Medicine (Baltimore). 2016 Mar;95(9):e2891. doi: 10.1097/MD.0000000000002891.

21.

IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.

Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y, Wu H, Renauer P, Del Mar Ayala Gutiérrez M, Castillo Palma MJ, Ortega Castro R, Fernández-Roldán C, Raya E, Faria R, Carvalho C, Alarcón-Riquelme ME, Xiang Z, Chen J, Li F, Ling G, Zhao H, Liao X, Lin Y, Sawalha AH, Lu Q.

Ann Rheum Dis. 2016 Nov;75(11):1998-2006. doi: 10.1136/annrheumdis-2015-208410. Epub 2016 Jan 19.

22.

Morphea-like plaques, induration of the extremities, and eosinophilia.

Magro-Checa C, Orgaz-Molina J, Lafèbre SR, Rosales-Alexander JL, Arias-Santiago S, Raya E.

Cleve Clin J Med. 2015 May;82(5):283-4. doi: 10.3949/ccjm.82a.13126. No abstract available.

23.

Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.

Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD, Raya E, Magro-Checa C, Vasilopoulos Y, Sarafidou T, Caliz R, Ferrer MA, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco FJ, Moreno-Ramos MJ, Fernández-Nebro A, Ordóñez MC, Alegre-Sancho JJ, Narváez J, Navarro-Sarabia F, Moreira V, Valor L, García-Portales R, Marquez A, Martin J, Gómez-Reino JJ, Gonzalez A.

Pharmacogenomics J. 2016 Apr;16(2):137-40. doi: 10.1038/tpj.2015.29. Epub 2015 Apr 21.

PMID:
25896535
24.

Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.

Montes A, Perez-Pampin E, Navarro-Sarabia F, Moreira V, de la Serna AR, Magallares B, Vasilopoulos Y, Sarafidou T, Fernández-Nebro A, Ordóñez Mdel C, Narváez J, Cañete JD, Marquez A, Pascual-Salcedo D, Joven B, Carreira P, Moreno-Ramos MJ, Caliz R, Ferrer MA, Garcia-Portales R, Blanco FJ, Magro C, Raya E, Valor L, Alegre-Sancho JJ, Balsa A, Martin J, Plant D, Isaacs J, Morgan AW, Barton A, Wilson AG; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Gómez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2015 Mar 18;17:63. doi: 10.1186/s13075-015-0571-z.

25.

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM; EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology).

Medicine (Baltimore). 2015 Jan;94(1):e267. doi: 10.1097/MD.0000000000000267.

26.

Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain: A Conjoint Analysis.

Martin E, Rodriguez M, Ibero I, Raya E, Nolla JM, Nocea G, Aragon B, Lizán L, Paz S.

Value Health. 2014 Nov;17(7):A537. doi: 10.1016/j.jval.2014.08.1717. Epub 2014 Oct 26. No abstract available.

27.

Preferences of Spanish Patients Over the Attributes of Biological Agents for the Treatment of Rheumatic Diseases Depending On the Administration Route.

Rodriguez M, Ibero I, Martin E, Nolla JM, Raya E, Aragon B, Nocea G, Lizán L, Aceituno S.

Value Health. 2014 Nov;17(7):A537. doi: 10.1016/j.jval.2014.08.1718. Epub 2014 Oct 26. No abstract available.

28.

Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Morado IC, Rodriguez-Rodriguez L, Narváez J, Gómez-Vaquero C, Miranda-Filloy JA, Martínez-Taboada VM, Ríos R, Sopeña B, Monfort J, García-Villanueva MJ, Martínez-Zapico A, Marí-Alfonso B, Sánchez-Martín J, Unzurrunzaga A, Raya E, de Miguel E, Hidalgo-Conde A, Blanco R, González-Gay MÁ, Martín J; Spanish GCA Consortium.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S30-3. Epub 2014 Apr 7.

PMID:
24709033
29.

Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.

Márquez A, Ferreiro-Iglesias A, Dávila-Fajardo CL, Montes A, Pascual-Salcedo D, Perez-Pampin E, Moreno-Ramos MJ, García-Portales R, Navarro F, Moreira V, Magro C, Caliz R, Ferrer MA, Alegre-Sancho JJ, Joven B, Carreira P, Balsa A, Vasilopoulos Y, Sarafidou T, Cabeza-Barrera J, Narvaez J, Raya E, Cañete JD, Fernández-Nebro A, Ordóñez Mdel C, de la Serna AR, Magallares B, Gomez-Reino JJ, González A, Martín J.

Arthritis Res Ther. 2014 Mar 11;16(2):R66. doi: 10.1186/ar4504.

30.

PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.

Oparina NY, Delgado-Vega AM, Martinez-Bueno M, Magro-Checa C, Fernández C, Castro RO, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Witte T, Lauwerys BR, Endreffy E, Kovács L, Escudero A, López-Pedrera C, Vasconcelos C, da Silva BM, Frostegård J, Truedsson L, Martin J, Raya E, Ortego-Centeno N, de Los Angeles Aguirre M, de Ramón Garrido E, Palma MJ, Alarcon-Riquelme ME, Kozyrev SV.

Ann Rheum Dis. 2015 Mar;74(3):e14. doi: 10.1136/annrheumdis-2013-204909. Epub 2014 Feb 17.

PMID:
24534757
31.

Standards of care for patients with spondyloarthritis.

Abad MÁ, Ariza RA, Aznar JJ, Batlle E, Beltrán E, de Dios Cañete J, de Miguel E, Escudero A, Fernández-Carballido C, Gratacós J, Loza E, Linares LF, Montilla C, Ramos MM, Mulero J, Queiro R, Raya E, Lozano CR, Moreno JR, Sanz J, Silva-Fernández L, Torre Alonso JC, Zarco P, Fernández-Sueiro JL, Juanola X; 2e study group; Spanish Society of Rheumatology.

Rheumatol Int. 2014 Feb;34(2):165-70. doi: 10.1007/s00296-013-2934-6. Epub 2014 Jan 4. Review.

PMID:
24390635
32.

Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome.

Dávila-Fajardo CL, Márquez A, Pascual-Salcedo D, Moreno Ramos MJ, García-Portales R, Magro C, Alegre-Sancho JJ, Balsa A, Cabeza-Barrera J, Raya E, Martín J.

Pharmacogenet Genomics. 2014 Jan;24(1):1-5. doi: 10.1097/FPC.0000000000000013.

PMID:
24253594
33.

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E; UK GCA Consortium; Spanish GCA Consortium, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Nov;72(11):1882-1886. doi: 10.1136/annrheumdis-2013-203641. Epub 2013 Aug 14.

34.

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease.

Cénit MC, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ, Fernandez-Sueiro JL, Magro C, Solans R, Castañeda S, Camps M, Hidalgo A, Espinosa G, González-Gay MA, González-Escribano MF, Martín J.

Hum Immunol. 2013 Feb;74(2):230-3. doi: 10.1016/j.humimm.2012.10.019. Epub 2012 Nov 2.

PMID:
23127549
35.

NPSR1 gene is associated with reduced risk of rheumatoid arthritis.

Robledo G, González-Gay MA, Fernández-Gutiérrez B, Lamas JR, Balsa A, Pascual-Salcedo D, Castañeda S, Blanco R, González-Alvaro I, García A, Raya E, Gómez-Vaquero C, Delgado M, Martín J.

J Rheumatol. 2012 Jun;39(6):1166-70. doi: 10.3899/jrheum.111205. Epub 2012 May 1.

PMID:
22548958
36.

Septic arthritis due to Cellulosimicrobium cellulans.

Magro-Checa C, Chaves-Chaparro L, Parra-Ruiz J, Peña-Monje A, Rosales-Alexander JL, Salvatierra J, Raya E.

J Clin Microbiol. 2011 Dec;49(12):4391-3. doi: 10.1128/JCM.05058-11. Epub 2011 Oct 12.

37.

Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region.

Martín JE, Alizadeh BZ, González-Gay MA, Balsa A, Pascual-Salcedo D, González-Escribano MF, Rodriguez-Rodriguez L, Fernández-Gutiérrez B, Raya E, Coenen MJ, van Riel P, Radstake TR, Kvien TK, Viken MK, Lie BA, Koeleman BP, Martín J.

J Rheumatol. 2011 Nov;38(11):2290-6. doi: 10.3899/jrheum.110361. Epub 2011 Oct 1.

PMID:
21965649
38.

No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data.

García-Bermúdez M, López-Mejias R, Rodriguez-Rodriguez L, Fernández-Gutierrez B, García A, Raya E, Ortiz AM, Coenen MJ, van Riel PL, Radstake TR, González-Gay MA, Martín J.

Hum Immunol. 2011 Sep;72(9):779-82. doi: 10.1016/j.humimm.2011.05.006. Epub 2011 May 24.

PMID:
21658422
39.

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.

Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, Balsa A, Pascual-Salcedo D, González-Gay MA, Raya E, Fernandez-Gutierrez B, González-Álvaro I, Bottini N, Witte T, Viken MK, Coenen MJ, van Riel PL, Franke B, den Heijer M, Radstake TR, Wordsworth P, Lie BA, Merriman TR, Martín J.

Arthritis Rheum. 2011 Feb;63(2):365-72. doi: 10.1002/art.30145. Erratum in: Arthritis Rheum. 2011 Mar;63(3):669.

40.

Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities.

Naredo E, Batlle-Gualda E, García-Vivar ML, García-Aparicio AM, Fernández-Sueiro JL, Fernández-Prada M, Giner E, Rodriguez-Gomez M, Pina MF, Medina-Luezas JA, Toyos FJ, Campos C, Gutiérrez-Polo R, Ferrer MA, Martínez O, Díaz-Torne C, Gonzalez T, Campos S, Queiro R, Castaño-Sánchez M, Aznar JJ, Bustabad S, Paez-Camino M, Tuneu R, Ruiz T, Mateo L, Pujol M, Ponce A, Ros I, Gallegos A, Moreno J, Gumbau D, Sianes M, Poveda-Elices MJ, Romero-Gómez M, Raya E; Ultrasound Group of the Spanish Society of Rheumatology.

J Rheumatol. 2010 Oct;37(10):2110-7. doi: 10.3899/jrheum.100136. Epub 2010 Sep 1.

PMID:
20810495
41.

Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis.

Martín JE, Alizadeh BZ, González-Gay MA, Balsa A, Pascual-Salcedo D, Fernández-Gutiérrez B, Raya E, Franke L, van't Slot R, Coenen MJ, van Riel P, Radstake TR, Koeleman BP, Martín J.

Arthritis Rheum. 2010 Nov;62(11):3183-90. doi: 10.1002/art.27648.

42.

Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis.

Robledo G, Rueda B, Gonzalez-Gay MA, Fernández B, Lamas JR, Balsa A, Pascual-Salcedo D, García A, Raya E, Martín J.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):25-9.

PMID:
20346234
43.

Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis.

Docampo E, Rabionet R, Riveira-Muñoz E, Escaramís G, Julià A, Marsal S, Martín JE, González-Gay MA, Balsa A, Raya E, Martín J, Estivill X.

Arthritis Rheum. 2010 May;62(5):1246-51. doi: 10.1002/art.27381.

44.

Investigation of CD69 as a new candidate gene for rheumatoid arthritis.

Rueda B, Fernandez-Gutierrez B, Balsa A, Pacual-Salcedo D, Lamas JR, Raya E, Gonzalez-Gay MA, Martin J.

Tissue Antigens. 2008 Sep;72(3):206-10. doi: 10.1111/j.1399-0039.2008.01094.x. Epub 2008 May 29.

PMID:
18627570
45.

Validity, reproducibility, and responsiveness of a twelve-joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis.

Naredo E, Rodríguez M, Campos C, Rodríguez-Heredia JM, Medina JA, Giner E, Martínez O, Toyos FJ, Ruíz T, Ros I, Pujol M, Miquel X, García L, Aznar JJ, Chamizo E, Páez M, Morales P, Rueda A, Tuneu R, Corominas H, de Agustín JJ, Moragues C, Mínguez D, Willisch A, González-Cruz I, Aragón A, Iglesias G, Armas C, Pablo Valdazo J, Vargas C, Calvo-Alén J, Juan-Mas A, Salvador G, Puigdollers A, Galíndez E, Garrido N, Salaberri J, Raya E, Salles M, Díaz C, Cuadra JL, Garrido J; Ultrasound Group of The Spanish Society of Rheumatology.

Arthritis Rheum. 2008 Apr 15;59(4):515-22. doi: 10.1002/art.23529.

46.

The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis.

Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, González-Gay MA, Martin J.

Ann Rheum Dis. 2008 Oct;67(10):1451-4. doi: 10.1136/ard.2007.080283. Epub 2008 Jan 16.

PMID:
18199597
47.

Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity.

Orozco G, García-Porrúa C, López-Nevot MA, Raya E, González-Gay MA, Martín J.

Ann Rheum Dis. 2006 May;65(5):687-8. Epub 2005 Sep 8. No abstract available.

48.

Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis.

Collado-Escobar MD, Nieto A, Matarán L, Raya E, Martín J.

J Rheumatol. 2000 Jun;27(6):1461-3.

PMID:
10852271
49.

[Active anti-A1 immunization by hemotherapy in an A2 recipient].

GUASCH J, RAYA E, VANRELL A.

Laboratorio. 1953 Sep;16(93):217-21. Undetermined Language. No abstract available.

PMID:
13131804
50.

[Active anti-A immunization by hemotherapy].

GUASCH J, RAYA E.

Laboratorio. 1953 Jun;15(90):501-5. Undetermined Language. No abstract available.

PMID:
13097973

Supplemental Content

Support Center